Life Sciences

T3's Life Sciences team is specifically built to meet the needs of biotechnology and medical device companies. A real estate advocate with a comprehensive knowledge of the challenges associated with owning or leasing advanced R&D facilities is critical for a life science company. T3's base business model of working exclusively with corporate occupants of real estate is particularly relevant in the "lab-ready" property market in which the ownership is generally concentrated among few developers. T3 clients have the luxury of knowing their best interests are being served exclusively by an advisor that understands their unique objectives.

T3's Life Science sector services include:

  • Strategic Planning
  • Market Analysis
  • Real Estate Site Search and Deal Negotiation
  • Sustainability Strategy and Implementation
  • LEED Analysis, Cost Benefit Evaluation
  • Government Incentives/ARRA Application and Procurement
  • National and Global Expansion
  • Project Management

T3's Life Science Success Stories

T3 Advisors News

JANUARY 31st, 2012

Meet Greg Hoffmeister, Co-founder and Managing Director at T3 Advisors

Master contract negotiator Greg Hoffmeister talks about his commitment to “tenant representation,” building trust, and feeling the pulse of the technology sector.

Read the full interview in Placeter >

+ Read More

Thought Leadership Blog

February 13th, 2012

The Resurgence of HealthCare IT and Emerging Tech Real Estate

This past month T3 Advisors attended the CEO Day at this year’s Health Innovation Summit in San Francisco.  The event was hosted by key sponsors Rock Health, Physic Ventures, FutureMed, Unilever and several others.  Jennifer Aaker, a current Professor at Stanford Graduate School of Business and recent author of The Dragon Fly Effect, kicked off the day discussing how companies cultivate admiration through brands.  We thought this was an invaluable discussion as we are contin

+ Read More

Connect